Accretion Nutraveda Limited
BBSE:ANL273.25
INR
-21.75
(-7.37%)
Accretion Nutraveda Limited
BSE:ANL
(Bombay Stock Exchange)
Recent
price
273.25
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
INR
•
in mil. unless spec.Working Capital
INR
•
in mil. unless spec.Growth Rates
INR
•
in mil. unless spec.Semi-annual Revenue
INR
•
in mil. unless spec.Semi-annual Earnings Per Share
INR
•
in mil. unless spec.Semi-annual Dividends Per Share
INR
•
in mil. unless spec.- Similar Companies
- Business
- Accretion Nutraveda Limited is an India-based Contract Development and Manufacturing Organization (CDMO) that specializes in the research, development, formulation, and commercial manufacturing of Ayurvedic, herbal, and nutraceutical wellness products. The company offers end-to-end contract manufacturing and private labeling services across multiple dosage forms, including tablets, encompassing film-coated, chewable, uncoated, and effervescent formulations; hard gelatin and hydroxypropyl methylcellulose (HPMC) capsules; oral liquids, including herbal syrups, suspensions, and tonics; oral powders, traditional churans, and dietary granules; external topical preparations, such as medicated oils, pain relief balms, ointments, creams, and therapeutic gels; and specialized botanical extracts and nutritional premixes. Its comprehensive portfolio spans multiple therapeutic and health management categories, including liver care and detoxification; bone, joint, and musculoskeletal health; digestive and gastrointestinal support; respiratory care; women’s reproductive and gynecological health; cardiovascular wellness; vitality, vigor, and immune support; pediatric and geriatric nutrition; memory, neurological, and cognitive enhancement; urinary tract care; and dermatological and hair care formulations. The company operates a World Health Organization Good Manufacturing Practice (WHO-GMP) and ISO-certified manufacturing facility situated at Sanand in Ahmedabad, Gujarat. Accretion Nutraveda serves a diversified client base consisting of multinational pharmaceutical corporations, fast-moving consumer goods (FMCG) enterprises, direct-to-consumer (D2C) wellness brands, institutional healthcare distributors, and merchant exporters. Its commercial footprint spans domestic distribution across India as well as international export markets across more than 20 countries, including the United States, Singapore, and Sri Lanka. Founded in March 2021 as Accretion Nutraveda Private Limited and headquartered in Ahmedabad, Gujarat, India, the company underwent a corporate restructuring and converted into a public limited entity under its current name in May 2025. In February 2026, Accretion Nutraveda Limited completed its Initial Public Offering (IPO) and listed its equity shares on the BSE SME platform (Ticker: BSE:ANL), raising approximately INR 24.77 crore in fresh capital. The company allocated the net proceeds to accelerate operational automation, install advanced high-speed manufacturing and packaging machinery at its Sanand facility, expand formulation capacities, and support ongoing working capital requirements to address increasing global demand for certified Ayurvedic and nutraceutical solutions.